Should endocrine therapy still be used as an initial treatment for postmenopausal women with metastatic breast cancer?

Future Oncol. 2017 Jul;13(16):1361-1364. doi: 10.2217/fon-2017-0101. Epub 2017 Jul 7.
No abstract available

Keywords: Endocrine positive breast cancer; endocrine resistance.

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Aromatase Inhibitors / adverse effects
  • Aromatase Inhibitors / therapeutic use*
  • Biomarkers, Tumor / genetics
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology
  • Drug Resistance, Neoplasm / genetics*
  • Estrogen Receptor alpha / genetics
  • Estrogen Receptor beta / genetics
  • Female
  • Humans
  • Neoplasm Metastasis
  • Postmenopause

Substances

  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Biomarkers, Tumor
  • ESR1 protein, human
  • ESR2 protein, human
  • Estrogen Receptor alpha
  • Estrogen Receptor beta